Forward P/S Multiple: Tactile Systems Technology, Inc. (TCMD)
The forward P/S multiple reflects market expectations, where 1.20 represents the current metric level. Tactile Systems Technology (TCMD) maintains stable revenue through regular sales of consumables for home lymphedema therapy systems. However, challenges may arise from revised insurance reimbursement terms and the pace of customer base expansion. The company's competitive advantage is secured by the uniqueness of its pneumatic devices for self-treatment.
Summary analytical data breakdowns for tactilemedical.com (TCMD)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Tactile Systems Technology|TCMD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Tactile Medical|TCMD - Company Aggregate Debts|Debt to Book Capitalization Ratio Tactile Medical|TCMD - Company Long-Term Debt|Company Current Liabilities Tactile Medical|Quick Ratio tactilemedical.com
- financial results and valuation multiples details:
TCMD - Company Net Income|Expected Profit Tactile Systems Technology|TCMD - Market Cap to Net Income Ratio|Projected Price to Earnings Tactile Medical|TCMD - PEG Multiple|EV/EBITDA Multiple Tactile Medical|TCMD - Operating income before deduction of amortization|Earnings per share for the last twelve months Tactile Medical|TCMD - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months tactilemedical.com|TCMD - Net earnings per share growth this year|Earnings growth forecast for next year Tactile Systems Technology
- sales and revenue indicators:
Fundamental company analysis:TCMD (Tactile Systems Technology Inc.)
To assess the credit quality of Tactile Systems Technology (TCMD), the analyst compares market capitalization with projected sales volumes, utilizing the forward P/S trend to determine the asset's degree of overvaluation amid tight monetary policy. The stability of this metric is supported by the company's technological leadership in the pneumatic compression systems segment and the implementation of cloud monitoring, where a rising multiple signals inflated market expectations.
Who Tactile Systems Technology competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|OM (Outset) - Forward Price-to-Revenue Multiple|Electromed - Forward Price to Sales|LNSR (LENSAR, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio avitamedical.com RCEL|Price-to-Projected Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Projected Price to Revenue|EDAP TMS - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR (beyondair.net) - Forward Price-to-Revenue Multiple|PFSA: Price to Expected Revenue Ratio|SSKN (STRATA Skin Sciences Inc.) - Forward P/S Multiple|Forward P/S Multiple glucotrack.com|Forward P/S Multiple NAOV|Forward Price-to-Revenue Multiple Venus Concept Corporation VERO|Nuwellis, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio AEMD (aethlonmedical.com)|TransEnterix - Forward P/S Multiple|Market Cap to Expected Sales Ratio Avinger Inc. AVGR|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|CUTR (Cutera Inc) - Price-to-Projected Revenue Ratio|KNW (Know Labs, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio inarimedical.com NARI|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK
